The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastases.
Yuya FujitaManabu KinoshitaTomohiko OzakiKoji TakanoKei KunimasaMadoka KimuraTakako InoueMotohiro TamiyaKazumi NishinoToru KumagaiHaruhiko KishimaFumio ImamuraPublished in: Neuro-oncology advances (2020)
Single BM with EGFR-mt performed better than other groups. Furthermore, effective local therapies were recommended to achieve better outcomes.